database
Real-World Data Analysis Confirms Pan-Cancer Predictiveness of Foundation Medicine TMB Caller
Premium
The company worked with clinical investigators to analyze outcomes data across more than 8,000 treated individuals, reconfirming the validity of its FDA-approved TMB indication.
Genomenon, Mirum Pharmaceuticals Partner for Rare Disease Data Sharing
Mirum has tapped Genomenon to produce a "landscape" of CYP27A1 gene variants to improve awareness and diagnosis of cerebrotendinous xanthomatosis.
Caris Life Sciences, Ontada Ink Deal to Integrate Genomic, Clinical Cancer Data
The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.
Ovation.io Collecting WGS, Clinical Data From 8,500 Patients on GLP-1 Meds
The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.
Guardant Health, Cota Partner to Provide Clinicogenomic Cancer Data Resource for Biopharma
The companies believe that creating a unified set of clinical and genomic data will help biopharma clients accelerate their development of new targeted therapies.